INFLUX (INFLUX) fundamentals
INFLUX is a listed company, part of the Pharmaceuticals sector, listed on the NSE as INFLUX (ISIN INE0MYZ01012). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What INFLUX does
Influx Healthtech Limited is an India-based healthcare product-focused company. The Company operates as a contract development and manufacturing organization. It specializes in a diverse range of products across several segments, including dietary/nutritional supplements, cosmetics, ayurvedic/herbal, veterinary feed supplements and homecare segments. This includes the production of active pharmaceutical ingredients and the manufacturing of finished dosage forms such as tablets, capsules, and injectables. It manufactures dietary and nutritional supplements in the form of tablets, capsules, powders, liquid orals, soft gels, lozenges, jellies, oral dispersible films, candies, gummies and effervescent tablets, and others. It manufactures cosmetics products for men and women, which include skincare and body care products, hair care and beard care solutions, and face masks and soaps. It manufactures ayurvedic formulations in the form of tablets, capsules, powder, liquid orals and others.
Valuation and market data
| Last close | ₹271.00 |
|---|---|
| Market capitalisation | ₹492 crore |
| Enterprise value | ₹491 crore |
| P/E (TTM) | 0.15 |
| Price to book | 13.62 |
| Price to sales (TTM) | 1.45 |
| Book value per share | ₹19.90 |
| Dividend yield | 0.00% |
| Sector | Pharmaceuticals |
| Industry | — |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹148 crore | ₹27 crore | ₹21 crore | 0.00 |
Figures are as reported (consolidated), in ₹ crore.
Shareholding pattern
As of Mar 2026:
| Promoters | 73.5% |
|---|---|
| Foreign institutions (FII) | 0.2% |
| Mutual funds | 0.0% |
| Other domestic institutions | 5.7% |
| Retail and others | 20.7% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.